Trial Outcomes & Findings for Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption (NCT NCT00427804)
NCT ID: NCT00427804
Last Updated: 2013-02-04
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
9 participants
Primary outcome timeframe
12 Weeks
Results posted on
2013-02-04
Participant Flow
Recruitment was conducted July 2007 to August 2008 at the Atlanta VA Medical Center.
Subjects included those with Crohn's disease and healthy controls.
Participant milestones
| Measure |
Healthy Control
|
Crohn's Disease
Subjects with stable Crohn's disease
|
|---|---|---|
|
Overall Study
STARTED
|
4
|
5
|
|
Overall Study
COMPLETED
|
4
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
Baseline characteristics by cohort
| Measure |
Healthy Control
n=4 Participants
|
Crohn's Disease
n=5 Participants
Subjects with stable Crohn's disease
|
Total
n=9 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age Continuous
|
42.40 years
STANDARD_DEVIATION 5 • n=5 Participants
|
35.5 years
STANDARD_DEVIATION 10 • n=7 Participants
|
39.3 years
STANDARD_DEVIATION 8 • n=5 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
4 participants
n=5 Participants
|
5 participants
n=7 Participants
|
9 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 WeeksOutcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 7 weekFractional absorption of calcium (see citation for complete details)
Outcome measures
| Measure |
Healthy Control
n=4 Participants
|
Crohn's Disease
n=5 Participants
Subjects with stable Crohn's disease
|
|---|---|---|
|
Fractional Absorption of Calcium
|
71 Percentage of absorption
|
115 Percentage of absorption
|
Adverse Events
Healthy Control
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Crohn's Disease
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place